Insider Transactions in Q4 2020 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 20
2020
|
Bobak R. Azamian President/CEO and Board Chair |
BUY
Conversion of derivative security
|
Direct |
1,750
+50.0%
|
-
|
|
Oct 20
2020
|
Bobak R. Azamian President/CEO and Board Chair |
BUY
Conversion of derivative security
|
Indirect |
21,575
+1.72%
|
-
|
|
Oct 20
2020
|
Michael Ackermann Director |
BUY
Conversion of derivative security
|
Direct |
63,185
+2.49%
|
-
|
|
Oct 20
2020
|
Jason E. Tester Director |
BUY
Open market or private purchase
|
Indirect |
171,875
+8.99%
|
$2,750,000
$16.0 P/Share
|
|
Oct 20
2020
|
Jason E. Tester Director |
BUY
Conversion of derivative security
|
Indirect |
1,777,456
+25.89%
|
-
|
|
Oct 20
2020
|
William J Phd Link |
BUY
Conversion of derivative security
|
Indirect |
1,112,301
+50.0%
|
-
|
|
Oct 20
2020
|
Vivo Capital Ix, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
250,000
+7.15%
|
$4,000,000
$16.0 P/Share
|
|
Oct 20
2020
|
Vivo Capital Ix, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,995,035
+28.34%
|
-
|
|
Oct 20
2020
|
Horowitz Limited Partnership Viii > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
15,625
+19.1%
|
$250,000
$16.0 P/Share
|
|
Oct 20
2020
|
Horowitz Limited Partnership Viii > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
50,547
+31.38%
|
-
|
|
Oct 20
2020
|
Horowitz Limited Partnership Viii > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
168,750
+8.08%
|
$2,700,000
$16.0 P/Share
|
|
Oct 20
2020
|
Horowitz Limited Partnership Viii > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,752,183
+22.23%
|
-
|
|
Oct 20
2020
|
Frazier Life Sciences Ix, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
312,500
+14.02%
|
$5,000,000
$16.0 P/Share
|
|
Oct 20
2020
|
Frazier Life Sciences Ix, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,604,657
+30.89%
|
-
|